Appointments

The Janssen Pharmaceutical Companies, part of Johnson & Johnson (J&J), has announced the appointment of Roz Bekker as the new managing director of Janssen UK and Ireland.

In her new role Bekker will lead the UK and Ireland’s commercial business strategy, aiming to deliver new solutions providing value to patients,healthcareprofessionalsand healthcare systems.

Previously, Bekker worked for Janssen’s EMEA Strategy Organisation as regional commercial strategy leader for Infectious Disease Vaccines (IDV) throughout this role she led the IDV Commercial Organisation and played an integral part in navigating the complexity of Janssen’s COVID-19 vaccine pandemic response. Having joined Janssen in 2005, Bekker worked in various roles with increasing leadership responsibility, across both medical and commercial functions.

Prior to working at Janssen, BekkerworkedasaclinicianinSouth Africa, relocating to the UK in 2011.

Commenting on her appointment, Bekker said: “I am delighted to be leading the UK and Ireland team at such an important time for the life sciences sector. I believe that there is considerable opportunity to strengthen existing partnerships between Government, the health service and industry to improve care and ensure timely access to innovative treatments for patients. I am privileged to join this talented team to help build on the outstanding work that is already in progress, as we continue to make a real difference to the lives of people, health systems and society as a whole.”